Creatine kinase isoenzyme MB catalytic activities in human serum, determined by ACA ion exchange chromatography and immunoinhibition, differ significantly, the correlation coefficient being 0.88. The reasons for this Variation are 1. interference of antibodies with the creatine kinase B subunit in the immunoinhibition assay, 2. nonreproducible elution of creatine kinase isoenzyme MB from the ion exchange resin in the ACA pack, due to varying protein concentrations in the serum samples and 3. increasing elution of creatine kinase isoenzyme MM from the ion exchange column caused by a preceding partial inactivation of creatine kinase isoenzyme MM.
Introduction
The myocardium is the only tissue containing relatively large amounts of creatine kinase (EC 2.7.3.2) isoenzyme MB (CK-MB). Diagnosis of myocardial injury therefore is generally possible from the appearance of this isoenzyme in the plasma together with the corresponding clinical Symptoms (1) . The use of creatine kinase isoenzyme MB activity in the diagnosis of myocardial infarction is thus well established (2) .
Numerous methods are available for measuring the isoenzymes of creatine kinase (3, 4) , each method having a different sensitivity and specificity. These include electrophoretic Separation (5), ion exchange column chromatography (6) , the immunoinhibition assay (7) and the radioimmunoassay (8) . While electrophoresis and ion exchange column chromatography give complete Separation of the three isoenzymes they aire cumbersome and only adequate for detecting creatine kinase isoenzyme MB catalytic activities at peak values. A Variation of ion exchange column chromatography is the method used by the ACA (Du Pont), in which a mixed anion-cation exchange chromatography column is used with a pH near the isoelectric point of creatine kinase isoenzyme MB so that most of the enzyme is not retained by the ion exchange resin (9) . Its activity is then determined automatically in the eluate. Electrophoresis and radioimmunoassay are not practical for general laboratory use, but the immunoinhibition method and the ACA method are in conimon use.
However, a reevaluation of the ACA method was necessary because the correlation between the creatine kinase isoenzyme MB catalytic activities obtained by the ACA and immunoinhibition methods is only partial (10) .
Quantitative determination of reduced NADP+ in the creatine kinase isoenzyme bands was carried out fluorometrically, using a Zeiss PMQ-II spectrophotometer (Fa. Zeiss, Oberkochen, Germany) (excitation at 340 nm, reflected emission at 450 nm).
Total creatine kinase catalytic activity was measured on the ACA II (starting point = 0, scale factor = 0.6228). Creatine kinase MB catalytic activities were determined on the ACA II (starting point = 0, scale factor = 0.6068 or 0.8422 or 0.3096) and with the immunoinhibition method (10 min preincubation, filter 365 nm, photometer Eppendorf, 25 °C). Solution A contained 1.5 mol/l magnesium sulphate, 25 mmol/l maleic acid and 1.25 mmol/I oxoglutaric acid. The sample was mixed with solution A in a ratio of 1+9 prior to measurement of creatine kinase isoenzyme MB cata* lytic activities on the ACA.
The serum samples used in this assay were obtained from different persons from the intensive care unit without special selection. The lowest and highest total creatine kinase catalytic activity concentration measured was 98 U/l and 4810 U/l. Diagnosis of acute myocardial infarction was by electrocardiogram with the exception of one case, which was diagnosed from serum enzyme catalytî c activities.
Isoelectric focussing of purified creatine kinase isoenzymes MM and MB was carried out with a LKB 110 ml column (Ampholine pH 3-7) according to the LKB instruction manual.
Effectors were added to serum or to bovine serum albumin containing samples in a volume ratio of 1+9.
Creatine kinase catalytic activities at 37 °C were converted to activities at 25 °C by multiplying by 0.42 (13) .
The coefficients of Variation (N = 25) for the methods were äs follows: immunoinhibition method creatine kinase MB 8.8% (35 U/l), electrophoresis creatine kinase MB 11.8% (22 U/l), ACA creatine kinase MB 6.0% (50 U/l), ACA creatine kinase MB with sample pretreatment by solution A 5.4% (56 U/l), ACA creatine kinase 5.7% (70 U/1).
Monotests for determination of creatine kinase isoenzyme MB catalytic activities with the immunoinhibition method were obtained from Fa. Boehringer, D-6800 Mannheim and Fa. Merck, D-6100 Darmstadt, Germany. Aspartate.aminotransferase (EC 2.6.1.1), alanine aminotransferase (EC 2.6.1.2) and adenylate kinase (EC 2.7.4.3) from porcine heart, glutamate dehydrogenase (EC 1.4.1.3) from bovine liver, human immunoglobulin G, organic and inorganic reagents and Substrates were commercial preparations from Fa. Boehringer, Fa. Merck, Fa. Sigma, D-8000 Mün-chen and Fa. Serva, D-6200 Heidelberg.
The comparision of the analytical procedures was carried out usî ng the standardized principal component analysis.
Materials and Methods
The creatine kinase isoenzyme MB from human myocardium was purified according to I.e. (11) with the modification that all Steps were carried out in the presence of l mmol/l EGTA. The purified creatine kinase isoenzyme MB preparation was homogeneous äs judged by disc gel electrophoresis (12) and contained no detectable creatine kinase isoenzyme MM (CK-MM) catalytic activity äs shown by electrophoresis on cellulose acetate Strips (5). Human creatine kinase isoenzyme B B was obtained by homogenization of 10 g uterus muscle in 100 ml of 0.05 mol/l Tris-HCl buffer pH 7.4 and 10000g centrifugation. The supernatant contained a pure creatine kinase isoenzyme BB preparation äs judged by electrophoresis on cellulose acetate Strips (5).
Electrophoresis was carried out according to I.e. (5) with several modifications: 0.05 mol/l barbituric acid buffer pH 8.6, time of electrophoresis 30 min at 25 °C, development of creatine kinase bands in the cellulose acetate Strips at 37 °C for 30 min on 2 g agar in 100 ml H 2 O, mixed with CK-monotest at a ratio of 1 + 1 (vol/ vol).
Results
Effects of inatrix compositiön on the creatine kinase isoenzyme MB determination by the ACA method
Constituents tested
Several constituents normally present in plasma were tested for their effect on the ACA method, üs-ing concentrations exceeding the normal fange. H + -concentration (pH 7.6, pH 7.2) lactic acid (6.0 -mmol/l), cholic acid (400 mg/1), cholesterol (2 g/l), bilirubin (10 mg/1), protoporjjhyrin (50 g/l), glutamate dehydrogenase (4000 U/l), aspartate amino-transferase (4000 U/l), alanine aminotransferase (4000 U/1) and adenylate kinase (4000 U/l) did not modify the ACA creatine kinase MB values when added to purified creatine kinase MB in bovine serum albumin Solutions (80 g/l).
A human serum pool containing varying Contents of added creatine kinase isoenzymes BB or MM and containing no creatine kinase MB catalytic activity was tested by the ACA creatine kinase MB method (tab. 1). Creatine kinase MM is retained (99%) by the ACA column, creatine kinase BB is partially (19-40%) eluted so that falsely high creatine kinase MB catalytic activities are obtained.
Tab. 1. Effects of human creatine kinase MM and BB on the creatine kinase MB assay on the ACA. The enzymes were added in the indicated catalytic activity concentration (25 °C) to a human serum pool containing no creatine kinase activity. The creatine kinase MB activity was determined on the ACA with the factor 0.6068 and was then corrected to 25 °C by the factor 0.5829. The only other known constituent which significantly irifluences the creatine kinase MB values obtained by the ACA is total protein. It modifies the retention of creatine kinase MB on the ion exchange column in the ACA pack ( fig. 1 ), Increasing plasma protein or bovine serum albumin or human ifrimunoglobulin G conce trations cause an appropriate increase of creatine kinase elution from the column s indicated by increased catalytic concentrations measured by the ACA (an increase of l g/l serum protein corresponds to an increase of l U/l, ACA factor 0.6068). Other nknown constit ents present in human serum modify· the elution of creatine kinase from the ACA column. Therefore, a dilution of serum is not possible, even if a solution of bovine serum albumin is used for dilution ( fig. 2 ). 
Influence of solution A on creatine kinase MB determination by the ACA method
When commercially available porcine heart aspartate aminotransferase was tested for its effect on the determination by the ACA it was observed that the obtained values were in good agreement with the creatine kinase activities added to the matrix. This improved elution from the ACA column, however, was not caused by the aspartate aminotransferase but by the stabilization mixture present in the aspartate aminotransferase solution. This mixture consist-ed of ammonium sulphate, maleate and 2-oxoglutarate. After exchanging ammonium sulphate for magnesium sulphate this solution A was tested for its influence on the determination of creatine kinase activities in human serum by the ACA (figs. 1-3, tab. 1).
Addition of solution A to serum samples reduces the effects of serum protein ( fig. 1 ) and other serum constituents ( fig. 2) When serum samples containing added purified creatine kinase MB and creatine kinase MM are incubated at room temperature for several days, an apparent increasing creatine kinase MB catalytic activity is measured by the ACA (tab. 2). This is due to the creatine kinase MM present in the serum matrix or due to the added creatine kinase, which is not completely retained by the ion exchange column. After sample pretreatment with solution A this increased elution of creatine kinase MM from the column in the ACA pack, is not observed. 
Correlation of the immunoinhibition and the ACA method
The correlations of creatine kinase MB catalytic activities in the serum of 28 patients suffering from acute myocardial infarction measured by the immunoinhibition method (25 °C) and the ACA methods When human serum samples containing varying catalytic activities of added purified creatine kinase MB are measured on the ACA in the total creatine kinase channel (25 °C) and in the creatine kinase MB channel (factor 0.3096) after pretreätment with solution A, values for total creatine kinase and creatine kinase MB are identical. Following the correction of creatine kinase MB activities obtained for the 28 serum samples after pretreatment with solution A, using the faetor 0.3096 instead of 0.6068, the values compare well with the activities obtained by the immunoinhibition (fig. 6) ; The slope is now 1.03, the coefficient of correlation tf.92. 
Inhibition of creatine kinase B subunit by anti-creatine kinase MM antibodies
During the purification procedure of human heart creatine kinase MB it was observed that the creatine kinase catalytic MB activities obtained by the immunoinhibition method were always lower than the values measured by the total creatine kinase method, even when the creatine kinase MB preparations contained no detectable isoenzyme MM activity. This discrepancy was caused by a partial Inhibition of creatine kinase B subunit by the anti-creatine kinase MM antibodies present in the immunoinhibition test ( fig. 7 ). This Inhibition is also observed when preparations are preincubated in 200 mmol/ N-acetylcysteine and when creatine kinase MB preparations were used which had been separated from creatine kinase isoenzyme MM by a single purification step (human heart homogenate was applied to DEAESepharose A 50 and creatine kinase MB was eluted according to . . (11)).
Discussion
The original ACA method for determination of creatine kinase MB catalytic activities shows several limitations. Dilution of the samples is not possible and 30-40% of the creatine kinase MB in the serum sample is retained on the column (9) so that a correction of the obtained values is necessary.
When using the immunoinhibition method for measurement of creatine kinase MB activities it must be presupposed that the creatine kinase B subunit remains active after incubation of the serum with the creatine kinase MM antibodies. This cannot be guaranteed äs is seen in figure 7 , where an apparent 20% Inhibition of the purified creatine kinase B subunit by creatine kinase MM antibodies is observed. The same Inhibition by creatine kinase MM antibodies is observed when creatine kinase MB preparations are used which have been separated from the creatine kinase MM by a single chromatography step, thus largely preventing possible denaturation of the creatine kinase B molecule. Use of monotests for the immunoinhibition method from another commercial source yielded identical results. Similar observations have been reported by other authors (14) . It is not clear whether the antibodies against the creatine kinase M subunit present in the immunoinhibition monotest inhibit the creatine kinase B subunit in native serum äs well.
If an Inhibition of creatine kinase B subunit is excluded, then the above described effects must be explained by different turnover numbers of the subunits M and B, and may be based on a differential course of inactivation of the subunits. It is known that the thermolability of the creatine kinase isoenzymes increases in the order creatine kinase isoenzyme MM, MB and BB (15) . This preferential inactivation of the creatine kinase B subunits also occurs in vivo (16) and results in a shift of remaining catalytic activity toward creatine kinase MM. In either case, use of the immunoinhibition method for determination of creatine kinase MB catalytic activities is limited to serum samples where the creatine kinase subunit B activity is not affected, i.e. to serum samples from persons suffering from a fresh acute myocardial infarction. It is known (21) that the concentration of creatine kinase B remains elevated lortger than its catalytic activity, and that the elimination kinetics for catalytic activity and concentratiön are different.
In addition, an increased creatine kinase B value from the immunoinhibition method might be difficult to Interpret, if creatine kinase BB is also possibly present in the plasma. While most diseases leading to activities in plasma do not present a difficult diagnostic problem in relation to acute myocardial infarction (17), this is not true in the case of anoxic brain injury after cardiac arrest (18) . If creatine kinase BB is present in serum samples which are tested for creatine kinase MB activity, the values derived from the immunoinhibition method are falsely increased by 200% of the residual creatine kinase BB activity, whereas the creatine kinase MB values obtained by the ACA are only, increased by 22-29% of the residual creatine kinase BB activity.
While the ACA method is not disturbed by many of the metabolites present in plasma (tab. 1), the total protein content in the sample is decisive in obtaining acceptable values. Differences in plasma protein concentratiön is one of the reasons for a variable retention of creatine kinase MB on the ion exchange column. This was first shown by I.e. (19) and later in greater detail by I.e. (20) .
When solution A is added to the samples, the determination of creatine kinase catalytic activity on the ACA is significantly improved and reproducible values are obtained. The effect of protein concentratiön in the serum sample is eliminated and dilution of serum samples with a bovine serum albumin solution is possible. Of all the methods compared, the best diagnostic sensitivity and specificity are obtained with the inodified ACA method ( fig. 6 , tab. 3) and a significant Separation is observed of the infarction -samples ( fig. 8 ). There are two reasons for the improvement of the ACA creatine kinase MB determination due to pretreatment with solution A. Since creased retention of creatine kinase MM on the column in the ACA pack s seen in table 2. After incubation of purified creatine kinase MM/MB combinations in serum matrix for several days at room temperature, increasing amounts of creatine kinase MM are eluted from the column, so that apparently higher creatine kinase MB activities are measured. The ACA ion exchange chromatography is carried out at pH 6.1 and the isoelectric points of human creatine kinase isoenzymes MM and MB are 6.95 and 4.85, respectively. The partial inactivation of creatine kinase MM causes a shift of isoelectric point toward pH 6. l s judged by a slightly faster migration of this partially inactivated creatine kinase MM in electrophoresis. As a result this modified creatine kinase MM is not retained s completely by the column s the fully active creatine kinase MM. We must assume that simil r effects occur in vivo (16) , so that sometimes falsely high creatine kinase MB activities are measured by the original ACA method.
